ManishKohliMDProfessor, Division of Oncology

PubMed

• A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating "BRCAness" Genotype (ROAR).
  Benson, M., Boucher, K., Sahu, K., Li, H., Mathew Thomas, V., Gupta, S., Kohli, M., Swami, U., Agarwal, N., Maughan, B.> ;The Oncologist. 2024 Mar 7
• Association of Baseline Pre-Diagnosis and Post-Diagnosis Obesity and Weight Change with Cardiovascular Risk and Survival Among Nonmetastatic Prostate Cancer Survivors.
  Kassandra Dindinger-Hill, Siqi Hu, Atticus Hickman, John Snyder, Vikrant Deshmukh, Michael Newman, Ankita Date, Carlos Galvao, Brock O'Neil, Christopher Dechet, Mia Ha...> ;Clinical Genitourinary Cancer. 2024 Feb 17
• Impact of Initial Timing of Metastatic Disease on Survival in Patients With Newly Diagnosed Metastatic Castration-Resistant Prostate Cancer Treated With Androgen Recep...
  Georges Gebrael, Nicolas Sayegh, Nishita Tripathi, Divyam Goel, Taylor McFarland, Hedyeh Ebrahimi, Blake Nordblad, Beverly Chigarira, Kamal Kant Sahu, Haoran Li, Alexa...> ;Urology Practice. 2024 Jan 1
• Reply by Authors.
  Georges Gebrael, Nicolas Sayegh, Nishita Tripathi, Divyam Goel, Taylor McFarland, Hedyeh Ebrahimi, Blake Nordblad, Beverly Chigarira, Vinay Mathew Thomas, Kamal Kant S...> ;Urology Practice. 2023 Oct 30
• 5-hydroxymethylcytosine sequencing in plasma cell-free DNA identifies unique epigenomic features in prostate cancer patients resistant to androgen deprivation therapy.
  Qianxia Li, Chiang-Ching Huang, Shane Huang, Yijun Tian, Jinyong Huang, Amirreza Bitaraf, Xiaowei Dong, Marja T Nevalanen, Jingsong Zhang, Brandon J Manley, Jong Y Par...> ;Medrxiv. 2023 Oct 16
• Cancer Prescriptions and Impact on Climate Change: Real or Imagined?
  Manish Kohli> ;JCO Oncology Practice. 2023 Sep 1
• 2 citations
  BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype.
  Heidi Fettke, Chao Dai, Edmond M Kwan, Tiantian Zheng, Pan Du, Nicole Ng, Patricia Bukczynska, Maria Docanto, Louise Kostos, Siavash Foroughi, Stephen Brown, Lisa-Jane...> ;Ebiomedicine. 2023 Sep 1
• Cost-effectiveness analysis of 7 treatments in metastatic hormone-sensitive prostate cancer: a public-payer perspective.
  Minkyoung Yoo, Richard E Nelson, Benjamin Haaland, Maura Dougherty, Zachary A Cutshall, Rhea Kohli, Rylee Beckstead, Manish Kohli> ;Journal of the National Cancer Institute. 2023 Nov 8
• Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808.
  Bradley C Carthon, Se Eun Kim, David F McDermott, Janice P Dutcher, Maneka Puligandla, Judith Manola, Michael Pins, Michael A Carducci, Elizabeth R Plimack, Leonard J ...> ;Clinical Genitourinary Cancer. 2023 Oct 1
• 1 citations
  Multi-Omic Integration of Blood-Based Tumor-Associated Genomic and Lipidomic Profiles Using Machine Learning Models in Metastatic Prostate Cancer.
  Shikai Fang, Shandian Zhe, Hui-Ming Lin, Arun A Azad, Heidi Fettke, Edmond M Kwan, Lisa Horvath, Blossom Mak, Tiantian Zheng, Pan Du, Shidong Jia, Robert M Kirby, Mani...> ;JCO Clinical Cancer Informatics. 2023 Jul 1
• 1 citations
  Systematic Analysis of Tissue-Derived and Biofluid Extracellular Vesicle miRNAs Associated with Prostate Cancer.
  Jeevan Larson, Mehmet Ozgun Ozen, Manish Kohli, Demir Akin, Utkan Demirci> ;Advanced Biology. 2023 Jul 1
• 6 citations
  Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer.
  Jamie M Sperger, Kyle T Helzer, Charlotte N Stahlfeld, Dawei Jiang, Anupama Singh, Katherine R Kaufmann, David J Niles, Erika Heninger, Nicholas R Rydzewski, Liguo Wan...> ;Clinical Cancer Research. 2023 Jun 13
• Dynamic assessment of serum chromogranin A and treatment response with abiraterone acetate in metastatic castration-resistant prostate cancer.
  Akeem R Lewis, Brian A Costello, Fernando Quevedo, Lance C Pagliaro, Cristobal Sanhueza, Richard M Weinshilboum, Krishna R Kalari, Liewei Wang, Manish Kohli, Winston T...> ;The Prostate. 2023 May 1
• 5 citations
  A Target Recycling Amplification Process for the Digital Detection of Exosomal MicroRNAs through Photonic Resonator Absorption Microscopy.
  Xiaojing Wang, Skye Shepherd, Nantao Li, Congnyu Che, Tingjie Song, Yanyu Xiong, Isabella Rose Palm, Bin Zhao, Manish Kohli, Utkan Demirci, Yi Lu, Brian T Cunningham> ;Angewandte Chemie. 2023 Apr 11
• Cost-Effectiveness Analysis of Six Immunotherapy-Based Regimens and Sunitinib in Metastatic Renal Cell Carcinoma: A Public Payer Perspective.
  Minkyoung Yoo, Richard E Nelson, Zachary Cutshall, Maura Dougherty, Manish Kohli> ;JCO Oncology Practice. 2023 Mar 1
• Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate Cancer.
  Jinyong Huang, Meijun Du, Alex Soupir, Liewei Wang, Winston Tan, Krishna R Kalari, Deepak Kilari, Jong Park, Chiang-Ching Huang, Manish Kohli, Liang Wang> ;Cancers. 2022 Sep 28
• Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment.
  Hugues Sicotte, Krishna R Kalari, Sisi Qin, Scott M Dehm, Vipul Bhargava, Michael Gormley, Winston Tan, Jason P Sinnwell, David W Hillman, Ying Li, Peter T Vedell, Rac...> ;Molecular Cancer Research. 2022 Dec 2
• 1 citations
  Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.
  Raquel Zimmerman, Mehmet A Bilen, Elisabeth I Heath, Lakshminarayanan Nandagopal, Umang Swami, Adam Kessel, Ellen Jaeger, Sergiusz Wesolowski, Edgar J Hernanadez, Jona...> ;The Oncologist. 2022 Oct 1
• 23 citations
  Photonic crystal enhanced fluorescence emission and blinking suppression for single quantum dot digital resolution biosensing.
  Yanyu Xiong, Qinglan Huang, Taylor D Canady, Priyash Barya, Shengyan Liu, Opeyemi H Arogundade, Caitlin M Race, Congnyu Che, Xiaojing Wang, Lifeng Zhou, Xing Wang, Man...> ;Nature Communications. 2022 Aug 8
• 1 citations
  Rapid quantification of microRNA-375 through one-pot primer-generating rolling circle amplification.
  Lucas D Smith, Siva Nalla, Chia-Wei Kuo, Manish Kohli, Andrew M Smith> ;The Analyst. 2022 Jun 27
• 13 citations
  Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216).
  Neeraj Agarwal, Catherine M Tangen, Maha H A Hussain, Shilpa Gupta, Melissa Plets, Primo N Lara, Andrea L Harzstark, Przemyslaw W Twardowski, Channing J Paller, Dylan ...> ;Journal of Clinical Oncology. 2022 Oct 1
• 7 citations
  Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer.
  Blossom Mak, Hui-Ming Lin, Edmond M Kwan, Heidi Fettke, Ben Tran, Ian D Davis, Kate Mahon, Martin R Stockler, Karen Briscoe, Gavin Marx, Alison Zhang, Megan Crumbaker,...> ;BMC Medicine. 2022 Mar 25
• 3 citations
  Dynamic changes in gene alterations during chemotherapy in metastatic castrate resistant prostate cancer.
  Winston Tan, Tiantian Zheng, Amy Wang, Joanna Roacho, Seng Thao, Pan Du, Shidong Jia, Jianjun Yu, Bonnie L King, Manish Kohli> ;Scientific Reports. 2022 Mar 18
• 8 citations
  Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer.
  Meixia Che, Aashi Chaturvedi, Sarah A. Munro, Samuel P. Pitzen, Alexander Ling, Weijie Zhang, Josh Mentzer, Sheng-Yu Ku, Loredana Puca, Yanyun Zhu, Andries M. Bergman,...> ;Nature Communications. 2021 Nov 4
• 15 citations
  Treatment Pattern and Outcomes with Systemic Therapy in Men with Metastatic Prostate Cancer in the Real-World Patients in the United States
  Umang Swami, Jennifer Anne Sinnott, Benjamin Haaland, Nicolas Sayegh, Taylor Ryan McFarland, Nishita Tripathi, Benjamin L. Maughan, Nityam Rathi, Deepika Sirohi, Rober...> ;Cancers. 2021 Sep 30
• Join now to see all

Journal Articles

• Docetaxel As Monotherapy or Combined With Ramucirumab or Icrucumab in Second-Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma: An Open-Label, Thr...  
  Petrylak DP, Tagawa ST, Kohli M, Eisen A, Canil C, Sridhar SS, Spira A, Yu EY, Burke JM, Shaffer D, Pan CX, Kim JJ, Aragon-Ching JB, Quinn DI, Vogelzang NJ, Tang S, Zh..., J Clin Oncol, 1/29/2016
• Copy Number Variations in urine cell free DNAs as biomarkers in advanced prostate cancer  
  Kohli M, Xia Y, Huang CC, Dittmar R, Du M, Wang Y, Liu H, Shenoy N, Wang L, OncoTargets & Therapy Journal, 1/1/2016
• Mutational landscapes of sequential prostate metastases and matched patient derived xenografts during Enzalutamide therapy  
  Kohli M, Wang L, Xie F, Sicotte H, Yin P, Dehm SM, Hart SN, Vedell PT, Barman P, Qin R, Mahoney DW, Carlson RE, Eckel-Passow JE, Atwell TD, Eiken PW, McMenomy BP, Wieb..., PLOS ONE, 1/1/2015
• ERNA: A graphic user interface-based tool optimized for large data analysis from high-throughput RNA sequencing  
  Yuan T, Huang X, Dittmar RL, Du M, Kohli M, Boardman L, Thibodeau SN, Wang L, BMC Genomics, 1/1/2014
• Health characteristics and sedentary behavior impact on prostate-specific antigen levels in a national US sample  
  Loprinzi PD, Kohli M, Journal of Physical Activity and Health, 1/1/2014
• Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients  
  Singh PK, Preus L, Hu Q, Yan L, Long MD, Morrison CD, Nesline M, Johnson CS, Koochekpour S, Kohli M, Liu S, Trump DL, Sucheston-Campbell LE, Campbell MJ, Oncotarget, 1/1/2014
• Pharmacogenetics- and pharmacogenomics-based rational clinical trial designs in oncology  
  Qin R, Kohli M, Pers. Med., 1/1/2013
• Cabozantinib Promising in Castration-Resistant Prostate Cancer (Expert Commentary)  
  Kohli M, Clinical Oncology, 1/1/2013
• An oberservational study of plasma vascular endothelial growth factors (VEGF) A and D expression in non-localized prostate cancer  
  Verdoorn BP, Feng C, Ricke WA, Sahasrabudhe DM, Kilari D, Kohli M, Journal of Men's Health, 1/1/2012
• Thrombin and thrombin receptor expression in prostate cancer  
  Kaushal V, Kohli M, Richard D, Chiles W, Mukunyadzi P, Prostate., 1/21/2005
• Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2, Interferon in Patients with Metastatic Renal Cell Carcinoma  
  Alikhan MA, Spencer HJ, Kohli M, J Clin Oncol, 1/1/2005
• Stage specific expression of VEGF A and D in prostate cancer  
  Kaushal V, Dennis R, Mukunyadzi P, Siegel E, Johnson D, Kohli M, Clin Cancer Res, 1/1/2005
• Join now to see all

Books/Book Chapters

• Germ Cell Tumor 
  Chapter: Medical Management of germ cell tumors. 
  Kohli M, Zhang B, Costello BASpringer2015
• DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology 
  Chapter: Hormonal agents. 
  Page 278 - 289Goetz MP, Erlichman C, Loprinzi CL, Kohli MEditors: DeVita VT Jr; Lawrence TS; Rosenberg SA.Wolters Kluwer, PhiladelphiaEdition 10th,2015
• Oncology In Primary Care 
  Chapter: Principles of antieoplastic therapy. 
  Page 217 - 236Kohli M, Lawrence TS, Reddy NM, Chinratanalab W, Goodman SA, Savani BN, Abrams DI, Hochster HSEditors: Rose MG; et al.Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia2013
• Oncology in Primary Care 
  Chapter: Principles of Anti-Neoplastic Therapy. 
  M Kohli, T Lawrence, S Goodman, B Savani, W Chinratanalab, N Reddy, D Abrams, H HochsterEditors: MG Rose, VT Devita Jr, TS Lawrence SA Rosenberg.Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia2012
• DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology 
  Chapter: Endocrine manipulation. 
  Page 508 - 219Goetz MP, Erlichman C, Kohli M, Loprinzi CLEditors: DeVita VT Jr; et al.Wolters Kluwer Health/Lippincott Williams & Wilkins, PhiladelphiaEdition 9th,2011
• CANCER: Principles and Practice of Oncology 
  Chapter: Endocrine Manipulations. 
  Goetz MP, Erlichman C, Loprinzi CL, Kohli M2010
• Encyclopedia of Cancer 
  Chapter: Hormonal Therapy in Prostate Cancer. 
  Kohli M, Tindall DEdition 3rd,2010
• Geriatric Nutrition The Health Professional's Handbook 
  Chapter: Impact of nutrition on the age related declines in heamatopoiesis. 
  Kohli M, Lipschitz DA, Chatta GSJones & Bartlett Publishers, AspenEdition 2nd,1999
• Join now to see all

Abstracts/Posters

• Association of androgen receptor V9 (ARV9) mRNA expression in metastatic tissue with early resistance to pre-chemotherapy abiraterone acetate/prednisone (AA/P)
  Manish Kohli, MD, ASCO Annual Meeting, 1/1/2016
• Association of androgen receptor V9 (ARV9) mRNA expression in metastatic tissue with early resistance to pre-chemotherapy abiraterone acetate/prednisone (AA/P)
  Manish Kohli, MD, ASCO GU Symposium, 1/1/2016
• The association of JAK2 polymorphisms with prognosis in castration-resistant prostate cancer (CRPC)
  Manish Kohli, MD, ASCO GU Symposium, 1/1/2016
• Comparative analysis of neuroendocrine phenotype in metastases from advanced prostate cancer and their corresponding primary tumor.
  Jimenez RE, Abbas J, Cheville JC, Kohli M, Laboratory Investigation, 1/1/2016
• Variation in trmt11 gene as a prognostic marker in advanced-stage castrate-resistant prostate cancer (crpc) patients.
  Zhang BYM, Mahoney DW, Riska SM, Cerhan JR, Teixeira Ribeiro RJ, Medeiros R, Monteiro C, Nogueira A, Mauricio J, Fraga AM, Calais-Da-Silva F, Costello BA, Dronca RS, P..., J Clin Oncol, 1/20/2015
• Androgen Receptor V9 (ARV9) mRNA expression in metastatic tissue is associated with early resistance to Pre-Chemotherapy Abiraterone Acetate/Prednisone (AA/P)
  Manish Kohli, MD, 22nd Annual Prostate Cancer Foundation Scientific Retreat, 1/1/2015
• Feasibility Analysis of Pathology and Genetic Yield from a Prospective Trial of Tissue Biopsies in Metastatic Castrate Resistant Prostate Cancer (mCRPC)
  Manish Kohli, MD, 22nd Annual Prostate Cancer Foundation Scientific Retreat, 1/1/2015
• Impact of biopsy of metastases on circulating tumor cell (CTC) counts in castrate resistant prostate cancer (CRPC)
  Manish Kohli, MD, 18th ECCO - 40th ESMO European Cancer Congress, 1/1/2015
• A molecular and clinico-pathological model for predicting abiraterone acetate/prednisone (AA/P) efficacy in metastatic castrate resistant prostate cancer (mCRPC)
  Manish Kohli, MD, ASCO Annual Meeting, 1/1/2015
• Androgen receptor (AR) based biomarker association with response to abiraterone acetate/prednisone (AA/P) in metastatic castrate resistant prostate cancer (mCRPC)
  Manish Kohli, MD, ASCO GU Symposium, 1/1/2015
• Change in Circulating Tumor cell (CTC) counts as predictive marker of response in chemotherapy naïve castrate resistant metastatic prostate cancer (CRPC) treated with ...
  Manish Kohli, MD, ASCO GU Symposium, 1/1/2015
• Feasibility Analysis of Pathology and Genetic Yield from a Prospective Trial of Tissue Biopsies in Metastatic Castrate Resistant Prostate Cancer (mCRPC)
  Manish Kohli, MD, ASCO GU Symposium, 1/1/2015
• Effect of metastatic site biopsy on circulating tumor cell (CTC) count in castrate resistant prostate cancer (CRPC) stage.
  Manish Kohli, MD, ASCO GU Symposium, 1/1/2015
• Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer.
  Wang, L, Xia S, Du M, Ditmar R, Yuan T, Guo Y, Wang Y, Lee A, Tschannen M, Worthey E, Jacobs H, Huang CC, Kohli M, AACR Annual Meeting, 1/1/2015
• Feasibility analysis of pathology and genetic yield from a prospective trial of tissue biopsies in metastatic castrate-resistant prostate cancer (mcrpc).
  Jimenez RE, Sicotte H, Barman P, Sinnwell JP, Eiken PW, Atwell TD, McMenomy BP, Tan W, Wu K, Bryce AH, Ho TH, Pitot HC, Quevedo F, Costello BA, Dronca RS, Moynihan TJ,..., J Clin Oncol, 1/1/2015
• Association of germline variation with androgen ablation (aa) failure in advanced hormone-sensitive prostate cancer (hspc).
  Kochuparambil ST, Zhang BY, Riska SM, Mahoney DW, McDonnell S, Lee AM, Quevedo F, Costello BA, Pitot HC, Ribeiro R, Medeiros R, Monteiro C, Nogueira A, Mauricio J, Fra..., J Clin Oncol, 1/1/2015
• Effect of metastatic site biopsy on circulating tumor cell (ctc) count in castrate resistant prostate cancer (crpc) stage.
  Kohli M, Eiken PW, McMenomy BP, Atwell TD, Tan W, Qin R, Carlson R, Campion MB, Wang LW, Costello BA, Pitot HC, Quevedo F, Scheel EA, Ho TH, Bryce AH, Paz-Fumagalli R,..., J Clin Oncol, 1/1/2015
• Androgen receptor (ar) based biomarker association with response to abiraterone acetate/prednisone (aa/p) in metastatic castrate resistant prostate cancer (mcrpc).
  Kohli M, Wang LG, Sicotte H, Qin R, Carlson R, Eckel-Passow J, Tan W, Wu K, Dehm S, Eiken PW, Jimenez RE, Cernigliaro J, Quevedo F, Costello BA, Pitot HC, Moynihan TJ,..., J Clin Oncol, 1/1/2015
• Interim results of a randomized phase 2 study of docetaxel with ramucirumab versus docetaxel in second-line advanced or metastatic urothelial carcinoma.
  Petrylak DP, Tagawa ST, Kohli M, Tang SD, Zhang H, Hamid O, Kauh JS, Walgren RA, Chi KN, J Clin Oncol, 1/1/2015
• Dose analysis of ASSURE (E2805): Adjuvant sorafenib or sunitinib for unfavorable renal carcinoma, an ECOG-ACRIN-led, NCTN phase 3 trial.
  Haas NB, Manola J, Flaherty K, Uzzo RG, Atkins MB, Dutcher JP, Wood CG, Kane CJ, Jewett MAS, Coomes B, Matin SF, Kuzel T, Sexton WJ, Wong YN, Choueiri TK, Pili R, Puza..., J Clin Oncol, 1/1/2015
• A molecular and clinico-pathological model for predicting abiraterone acetate/prednisone (AA/P) efficacy in metastatic castrate resistant prostate cancer (mCRPC).
  Kohli M, Qin R, Wang L, Sicotte H, Carlson R, Tan W, Jimenez RE, Wang L, Eckel-Passow J, Costello BA, Pitot HC, Quevedo F, Dronca RS, Wu K, Moynihan TJ, Ho TH, Bryce A..., J Clin Oncol, 1/1/2015
• Neuroendocrine phenotype expression patterns in metastases from advanced prostate cancer.
  Manish Kohli, MD, ASCO Annual Meeting, 1/1/2014
• Exosomal mir-1290 and mir-375 as prognostic markers in metastatic castrate resistant prostate cancer.
  Huang X, Yuan T, Liang M, Du M, Xia S, Dittmar RL, Sun Z, Lu Y, Thibodeau SN, Boardman L, Kohli M, Wang L, Cancer Res, 1/1/2014
• Chemohormonal therapy versus hormonal therapy for hormone naive high volume newly metastatic prostate cancer (prca): ecog led phase iii randomized trial.
  Sweeney C, Chen Y, Carducci M, Liu G, Jarrard D, Eisenberger M, Wong Y, Hahn NM, Kohli M, Vogelzang N, Cooney M, Dreicer R, Picus J, Shevrin D, Hussain M, Garcia J, Di..., Ann Oncol, 1/1/2014
• Exosomal microrna as prognostic biomarkers in metastatic castrate-resistant prostate cancer (mcrpc).
  Kohli M, Huang XY, Yuan TZ, Sun ZF, Costello BA, Quevedo F, Tan W, Nandy D, Longenbach S, Wang L, J Clin Oncol, 1/1/2014
• Join now to see all

Lectures

• Plasma cell free DNA (cfDNA) based somatic aberrations detected in treatment naïve metastatic hormone sensitive prostate cancer (mHSPC), hormonally ablated mHSPC and ... 
  2019 ASCO Annual Meeting - 6/1/2019
• A transcriptome analysis of castration resistant prostate cancer metastases in a prospective cohort study reveals high expression of AKT pathway genes predictive of lo... 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
• Liquid Biopsy Program in Advanced GU Cancers 
  Mayo Clinic, Rochester, MN - 1/1/2016
• Research Program in Advanced GU Malignancies 
  Mayo Clinic, Rochester, MN - 1/1/2016
• In Search of Response Biomarkers in Advanced Prostate Cancer Therapeutics 
  Mayo Clinic, Rochester, MN - 1/1/2016
• In search of a Response Biomarker in Advanced Prostate Cancer Therapeutics 
  University of California Davis, Davis, CA - 1/1/2016
• ACCP Prostate Cancer Course 
  Mayo Clinic, Rochester, MN - 1/1/2015
• Ethical Considerations in Pregnancy Related Research 
  Kawagoe, Japan - 1/1/2015
• Biomarker development in advanced prostate cancer and clinical applications. 
  University of Illinois at Urbana-Champaign, Urbana, IL - 1/1/2015
• Value of Blood Banking in India 
  Chicago, IL - 1/1/2015
• Prostate Cancer Medically Optimized Genome-Enhanced Therapy (PROMOTE) 
  Park Nicolett Health System, Minneapolis, MN - 1/1/2015
• Renal Cell and Bladder Cancer Management in 2014 
  1/1/2014
• How to Use National Datasets 
  1/1/2014
• Management of Hepatocellular Cancer and Liver Metastasis 
  Ludhiana, India - 1/1/2014
• Molecular Genetics in Prostate Cancer 
  Post Graduate Institute of Medical Education and Research, Chandigarh, Punjab, India - 1/1/2014
• Updates in the treatment of Metastatic prostate cancer and metastatic kidney cancer. 
  Geneva, Switzerland - 1/1/2014
• Genomic Application in Prostate Cancer 
  Seoul, South Korea - 1/1/2014
• Initiated Hospital to Hospital Collaboration between Mayo Clinic Cancer Center and Seoul National Hospital 
  Bundang Hospital, South Korea - 1/1/2014
• ASCO 2013: Updates in GU Oncology 
  Mayo Medical School, Rochester, MN - 1/1/2013
• Advances in Cancer Genetics Applied to Genito-Urinary Oncology 
  1/1/2013
• Prostate Cancer Medically Optimized Genome Enhanced Therapy in Castrate-Resistant Stage (PROMOTE) 
  1/1/2013
• Coagulation and Pregnancy and Regional Anesthesia/Analgesia 
  Bangkok, Thailand - 1/1/2013
• ASCO 2012: Updates in GU Oncology 
  Mayo Medical School, Rochester, MN - 1/1/2012
• Recommendations on PSA Screening for Prostate Cancer 
  Rochester, MN - 1/1/2012
• Updates in Genitourinary Oncology 
  Apollo Hospital, New Delhi, India - 1/1/2012
• Join now to see all